ProShare Advisors’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $577K | Buy |
+18,448
| New | +$577K | ﹤0.01% | 1049 |
|
|
2024
Q2 | – | Sell |
-5,286
| Closed | -$228K | – | 2020 |
|
|
2024
Q1 | $228K | Buy |
5,286
+565
| +12% | +$24.3K | ﹤0.01% | 1604 |
|
|
2023
Q4 | $217K | Buy |
+4,721
| New | +$217K | ﹤0.01% | 1592 |
|
|
2023
Q1 | – | Sell |
-5,172
| Closed | -$204K | – | 1921 |
|
|
2022
Q4 | $204K | Buy |
+5,172
| New | +$204K | ﹤0.01% | 1489 |
|
|
2022
Q1 | – | Sell |
-7,266
| Closed | -$227K | – | 2309 |
|
|
2021
Q4 | $227K | Buy |
+7,266
| New | +$227K | ﹤0.01% | 1955 |
|